Search research articles
Contact Us
Filters
Showing results (81-90 of 248) with videos related to
Page
of 25
Sort By:
Cancers
|
February 5, 2020
HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?
Hélène Losson, Michael Schnekenburger, Mario Dicato, et al.
Current Drug Targets
|
February 3, 2015
Roles of Apoptosis and Cellular Senescence in Cancer and Aging
Claudia Cerella, Cindy Grandjenette, Mario Dicato, et al.
Epigenomics
|
February 18, 2015
Histone deacetylase 6 in health and disease
Carole Seidel, Michael Schnekenburger, Mario Dicato, et al.
Current Pharmaceutical Biotechnology
|
April 7, 2011
Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents
Marie-Hélène Teiten, François Gaascht, Mario Dicato, et al.
Biochemical Pharmacology
|
August 27, 2013
Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions
Marie-Hélène Teiten, François Gaascht, Mario Dicato, et al.
Biochemical Pharmacology
|
January 28, 2012
DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs
Jessica Charlet, Michael Schnekenburger, Keith W Brown, et al.
Toxins
|
November 10, 2011
Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment
Marie-Hélène Teiten, Serge Eifes, Mario Dicato, et al.
Genes & Nutrition
|
May 4, 2011
Natural compounds as inflammation inhibitors
Marc Schumacher, Tom Juncker, Michael Schnekenburger, et al.
International Journal of Cell Biology
|
March 27, 2010
The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies
Cyril Sobolewski, Claudia Cerella, Mario Dicato, et al.
Epigenomics
|
December 1, 2011
Epigenomics of leukemia: from mechanisms to therapeutic applications
Cristina Florean, Michael Schnekenburger, Cindy Grandjenette, et al.
Page
of 25
Search research articles
Search
Showing results (81-90 of 248) with videos related to
Sort By:
Page
of 25
Cancers
|
February 5, 2020
HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?
Hélène Losson, Michael Schnekenburger, Mario Dicato, et al.
Current Drug Targets
|
February 3, 2015
Roles of Apoptosis and Cellular Senescence in Cancer and Aging
Claudia Cerella, Cindy Grandjenette, Mario Dicato, et al.
Epigenomics
|
February 18, 2015
Histone deacetylase 6 in health and disease
Carole Seidel, Michael Schnekenburger, Mario Dicato, et al.
Current Pharmaceutical Biotechnology
|
April 7, 2011
Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents
Marie-Hélène Teiten, François Gaascht, Mario Dicato, et al.
Biochemical Pharmacology
|
August 27, 2013
Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions
Marie-Hélène Teiten, François Gaascht, Mario Dicato, et al.
Biochemical Pharmacology
|
January 28, 2012
DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs
Jessica Charlet, Michael Schnekenburger, Keith W Brown, et al.
Toxins
|
November 10, 2011
Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment
Marie-Hélène Teiten, Serge Eifes, Mario Dicato, et al.
Genes & Nutrition
|
May 4, 2011
Natural compounds as inflammation inhibitors
Marc Schumacher, Tom Juncker, Michael Schnekenburger, et al.
International Journal of Cell Biology
|
March 27, 2010
The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies
Cyril Sobolewski, Claudia Cerella, Mario Dicato, et al.
Epigenomics
|
December 1, 2011
Epigenomics of leukemia: from mechanisms to therapeutic applications
Cristina Florean, Michael Schnekenburger, Cindy Grandjenette, et al.
Page
of 25